FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

35922211000001107: Ibandronic acid 150mg tablets (Consilient Health Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
111153401000001114 Ibandronic acid 150mg tablets (Consilient Health Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111153501000001113 Ibandronic acid 150mg tablets (Consilient Health Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ibandronic acid 150mg tablets (Consilient Health Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Consilient Health Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Consilient Health Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Consilient Health Ltd) Is a Ibandronic acid 150mg tablets true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Consilient Health Ltd) Has active ingredient Ibandronic acid true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Consilient Health Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Consilient Health Ltd) Has basis of strength substance Ibandronic acid true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Consilient Health Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Consilient Health Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Consilient Health Ltd) Has specific active ingredient Ibandronate sodium monohydrate true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Consilient Health Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Consilient Health Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ibandronic acid true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Consilient Health Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Consilient Health Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ibandronic acid 150mg tablets (Consilient Health Ltd) 1 tablet Has AMP True Ibandronic acid 150mg tablets (Consilient Health Ltd) Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Consilient Health Ltd) 3 tablet Has AMP True Ibandronic acid 150mg tablets (Consilient Health Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start